Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV	DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease	Active, not recruiting	Phase 3	2026-09-14		NCT04255849

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
H. Lee Moffitt Cancer Center and Research Institute	162
Instituto Nacional de Salud Publica, Mexico	5
Merck Sharp & Dohme LLC	650
National Cancer Institute (NCI)	3015
University of California, San Diego	337
University of Puerto Rico	18
University of Sao Paulo	128
Weill Medical College of Cornell University	276

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Instituto Nacional de Salud Pública, Mexico	Cuernavaca	Mexico	1
Universidade de São Paulo	São Paulo	Brazil	1
University of Puerto Rico AIDS Clinical Trials Unit	San Juan	Puerto Rico	1